CV Therapeutics, Astellas, TPG-Axon Capital sales and marketing update

Astellas' Astellas Pharma U.S. Inc. unit launched Lexiscan regadenoson injection in the U.S. for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI) studies. Astell...